Status:
COMPLETED
Designated Drug Use Investigation 1 of Follistim Injection (Study P06130)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Fertilization in Vitro
Eligibility:
FEMALE
Brief Summary
To evaluate dosage and administration method, efficacy and safety of Puregon and the relationship between background factors of patients and dose and administration method. Post-marketing surveys are...
Eligibility Criteria
Inclusion
- Patients who underwent IVF
Exclusion
- Patients with tumors of ovary, breast, uterus, pituitary or hypothalamus
- Pregnant or possible pregnant women, or lactating women
- Patients with undiagnosed atypical vaginal bleeding
- Patients with a history of hypersensitivity to any of the ingredients of this product.
- Patients with ovarian cysts or enlarged ovaries, not related to polycystic ovarian disease
Key Trial Info
Start Date :
November 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
1664 Patients enrolled
Trial Details
Trial ID
NCT00920361
Start Date
November 1 2005
End Date
March 1 2009
Last Update
February 4 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.